Logo image of ALBOA.PA

BOA CONCEPT SACA (ALBOA.PA) Stock Fundamental Analysis

EPA:ALBOA - Euronext Paris - Matif - FR0011365907 - Common Stock - Currency: EUR

18.75  +0.55 (+3.02%)

Fundamental Rating

3

ALBOA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ALBOA may be in some trouble as it scores bad on both profitability and health. ALBOA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALBOA has reported negative net income.
ALBOA had a positive operating cash flow in the past year.
ALBOA.PA Yearly Net Income VS EBIT VS OCF VS FCFALBOA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 1M -1M 2M 3M

1.2 Ratios

Industry RankSector Rank
ROA -0.25%
ROE -0.42%
ROIC N/A
ROA(3y)10.92%
ROA(5y)N/A
ROE(3y)20.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALBOA.PA Yearly ROA, ROE, ROICALBOA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 20 30

1.3 Margins

ALBOA's Gross Margin has been stable in the last couple of years.
ALBOA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5YN/A
ALBOA.PA Yearly Profit, Operating, Gross MarginsALBOA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

ALBOA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALBOA has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ALBOA has been reduced compared to a year ago.
ALBOA.PA Yearly Shares OutstandingALBOA.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 200K 400K 600K 800K
ALBOA.PA Yearly Total Debt VS Total AssetsALBOA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

ALBOA has an Altman-Z score of 2.18. This is not the best score and indicates that ALBOA is in the grey zone with still only limited risk for bankruptcy at the moment.
ALBOA has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 2.18
ROIC/WACCN/A
WACC8.57%
ALBOA.PA Yearly LT Debt VS Equity VS FCFALBOA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

ALBOA has a Current Ratio of 4.31. This indicates that ALBOA is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 3.60 indicates that ALBOA has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.31
Quick Ratio 3.6
ALBOA.PA Yearly Current Assets VS Current LiabilitesALBOA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

ALBOA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -103.16%.
Looking at the last year, ALBOA shows a very negative growth in Revenue. The Revenue has decreased by -44.18% in the last year.
ALBOA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.61% yearly.
EPS 1Y (TTM)-103.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-184.17%
Revenue 1Y (TTM)-44.18%
Revenue growth 3Y41.61%
Revenue growth 5YN/A
Sales Q2Q%-53.47%

3.2 Future

The Earnings Per Share is expected to grow by 80.05% on average over the next years. This is a very strong growth
ALBOA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.25% yearly.
EPS Next Y-46.94%
EPS Next 2Y122.69%
EPS Next 3Y80.05%
EPS Next 5YN/A
Revenue Next Year31.18%
Revenue Next 2Y24.38%
Revenue Next 3Y17.25%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALBOA.PA Yearly Revenue VS EstimatesALBOA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
ALBOA.PA Yearly EPS VS EstimatesALBOA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALBOA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 7.49 indicates a rather cheap valuation of ALBOA.
The average S&P500 Price/Forward Earnings ratio is at 20.44. ALBOA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.49
ALBOA.PA Price Earnings VS Forward Price EarningsALBOA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200 -250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALBOA.PA Per share dataALBOA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as ALBOA's earnings are expected to grow with 80.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y122.69%
EPS Next 3Y80.05%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBOA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOA CONCEPT SACA

EPA:ALBOA (5/9/2025, 7:00:00 PM)

18.75

+0.55 (+3.02%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.26%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.19M
Analysts86.67
Price Target25.5 (36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-26.47%
PT rev (3m)-26.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-44.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)25.99%
Revenue NY rev (3m)25.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.49
P/S 1.62
P/FCF N/A
P/OCF 19.33
P/B 1.15
P/tB 1.28
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)2.5
Fwd EY13.35%
FCF(TTM)-8.55
FCFYN/A
OCF(TTM)0.97
OCFY5.17%
SpS11.56
BVpS16.32
TBVpS14.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.25%
ROE -0.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.69%
FCFM N/A
ROA(3y)10.92%
ROA(5y)N/A
ROE(3y)20.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2336.22%
Cap/Sales 82.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.31
Quick Ratio 3.6
Altman-Z 2.18
F-Score4
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)249.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.25%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-184.17%
EPS Next Y-46.94%
EPS Next 2Y122.69%
EPS Next 3Y80.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-44.18%
Revenue growth 3Y41.61%
Revenue growth 5YN/A
Sales Q2Q%-53.47%
Revenue Next Year31.18%
Revenue Next 2Y24.38%
Revenue Next 3Y17.25%
Revenue Next 5YN/A
EBIT growth 1Y-121.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-94.55%
EBIT Next 3Y-37.63%
EBIT Next 5YN/A
FCF growth 1Y-229.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.95%
OCF growth 3YN/A
OCF growth 5YN/A